バイオ保存市場レポート：2031年までの動向、予測、競合分析

世界のバイオ保存市場の将来は、病院、バイオバンク、遺伝子バンク市場に機会があり、有望です。世界のバイオ保存市場は、2025年から2031年までのCAGRが28.1%で、2031年までに推定170億米ドルに達すると予想されています。この市場の主な促進要因は、研究開発投資の増加、バイオバンクの進歩、新生児の臍帯血幹細胞を保存する傾向の高まり、再生医療研究への投資の増加、個別化医療への需要の高まりです。

• Lucintelの予測では、タイプ別では、バイオバンク需要の増加、DNA、血漿、幹細胞、組織研究での広範な使用、広範な採用、高コスト効率、低メンテナンスにより、機器が予測期間中に高い成長を遂げる見込みです。
• 最終用途産業別では、研究者の間でバイオ保存に対する認識が高まっていること、精子バンクや卵子バンクの数が増加していること、生殖補助医療技術の採用、バイオ製薬企業と国立バイオバンクとの提携、病院での組織保存センターなどが理由で、バイオバンクが最大セグメントであり続けると思われます。
• 地域別では、生物医学研究分野における一貫した医薬品開発と先進治療、慢性疾患のハイエンド治療を必要とする患者の増加、バイオ保存製品とサービスに対する需要の高さから、北米が予測期間中に最も高い成長を遂げると予想されます。

バイオ保存市場の戦略的成長機会

バイオ保存市場は、技術の進歩と様々な分野での応用の拡大により急速に拡大しています。生物材料の品質と完全性を確保するための効果的な保存方法に対するニーズの高まりを反映して、いくつかの用途で主要な成長機会が生まれています。これらの機会は、バイオバンク、再生医療、医薬品開発、診断、個別化医療などの分野に及んでいます。これらの成長機会を理解することは、利害関係者が市場の成長とイノベーションを活用するために戦略を調整するのに役立ちます。

• バイオバンクの拡大：バイオバンクは、大規模かつ高品質な生物学的サンプルリポジトリに対する需要の高まりから、重要な成長分野となっています。高度なバイオバンクインフラの開発とサンプル管理技術の向上により、サンプルの収集、保管、利用がより適切に行えるようになりました。この拡大は、保存状態の良い多様な生物試料を提供することで、ゲノム研究、個別化医療、創薬研究をサポートします。バイオバンクインフラへの投資は、研究能力を強化し、疾患の解明や標的治療法の開発における飛躍的進歩を促進することができます。
• 再生医療の進歩：再生医療はバイオ保存に大きな成長機会をもたらします。幹細胞治療や組織工学などの技術は、細胞の生存能力や機能性を維持するために正確な保存方法を必要とします。凍結保存と保存技術の革新は、こうした応用をサポートするために不可欠です。再生医療が進歩するにつれて、信頼性の高い生体保存ソリューションの必要性が高まり、再生療法特有の要件に対応し、その有効性を高める専門技術を開発する機会が企業にもたらされています。
• 医薬品開発の成長：製薬業界はバイオ医薬品や複雑な医薬品に重点を置いているため、高度なバイオ保存法に対する需要が高まっています。モノクローナル抗体やワクチンなどの生物製剤の保存には、製品の安定性と有効性を確保するため、保存条件の厳格な管理が必要です。こうしたデリケートな製品の保存期間と取り扱いを改善する新しい保存技術を開発する機会は存在します。製薬会社がバイオ保存プロセスの最適化を模索する中、この分野には大きな成長の可能性があります。
• 診断検査における革新：診断検査の複雑化と量の増加により、診断用サンプルの管理と保存にバイオ保存の機会が生まれています。保存技術の進歩は、診断におけるサンプルの品質、精度、信頼性を向上させることができます。血液、組織、遺伝物質など多様な種類のサンプルを扱うことができる堅牢なバイオ保存ソリューションの開発は、成長する診断業界を支える上で極めて重要です。これにより、診断検査能力を高める革新的な保存技術のニッチ市場が形成されます。
• 個別化医療：個別化医療は急速に拡大しており、個人の遺伝子プロファイルに基づいて治療を調整するための高度なバイオ保存ソリューションが必要とされています。ゲノム、プロテオミクス、その他の生物学的データの保存は、個別化治療の開発と提供に不可欠です。企業には、個別化医療の研究や応用の拡大をサポートする特殊なバイオ保存システムを構築する機会があります。個別化医療特有のニーズに対応することで、バイオ保存プロバイダーは、個別化された患者ケアに焦点を当てた急成長市場に参入することができます。

バイオ保存の戦略的成長機会は、バイオバンク、再生医療、医薬品開発、診断検査、個別化医療に及んでいます。各用途は、技術革新と市場拡大のためのユニークな機会を提供しています。これらの機会を活用することで、利害関係者は自社の製品を強化し、関連分野の進歩をサポートし、バイオ保存市場全体の成長に貢献することができます。

バイオ保存市場の促進要因・課題

バイオ保存市場は、技術の進歩、経済要因、規制の枠組みなど、さまざまな市場促進要因・課題の影響を受けています。これらの要因を理解することは、市場をナビゲートし成長機会を見極める上で極めて重要です。以下の分析では、バイオ保存業界を形成する主な促進要因と課題を探り、その意味合いと影響を明らかにします。

バイオ保存市場の促進要因には以下のようなものがある：

• 技術の進歩：技術的進歩：凍結保存、保存システム、モニタリング技術における技術革新は、バイオ保存市場の成長を促進する主要要因です。改良された凍結保護剤、自動化された保存ソリューション、リアルタイムのモニタリングシステムなどの進歩は、保存方法の効率性と信頼性を高める。これらの技術は、これまでの限界に対処し、コストを削減し、研究、医薬品、個別化医療における新しいアプリケーションの開発をサポートします。
• バイオバンク需要の増加：バイオバンクに対する需要の高まりは、バイオ保存市場の重要な促進要因です。バイオバンクは、研究や臨床応用のために大量の生物学的サンプルを保管するために不可欠です。個別化医療、ゲノミクス、創薬が進展するにつれて、広範で保存状態の良いサンプル保管庫の必要性が高まっています。バイオバンクのインフラと技術への投資は、この需要を満たし、現在進行中の研究開発を支援する上で極めて重要です。
• 再生医療の成長：幹細胞治療や組織工学を含む再生医療の台頭は、高度なバイオ保存法に対する需要を促進しています。細胞、組織、臓器の効果的な保存は、それらの生存可能性と機能性を維持するために不可欠です。凍結保存と保存技術の革新は再生医療特有のニーズに対応し、特殊な保存ソリューションを開発する企業に成長機会をもたらしています。
• 医薬品・バイオ医薬品市場の拡大：生物製剤や複雑な医薬品の開発による医薬品・バイオ医薬品市場の開発は、バイオ保存ソリューションの需要を促進しています。バイオ医薬品は、安定性と有効性を確保するために厳しい保存条件が要求されます。これらの製品の保存期間と取り扱いを向上させる保存技術の進歩は、この分野の成長を支える上で極めて重要です。
• 個別化医療への注目の高まり：個別化医療は、遺伝子、プロテオミクス、その他の生物学的データに対する高度な保存方法を必要とし、バイオ保存市場の成長を促進します。個人のプロファイルに基づいて治療をカスタマイズする能力には、生物学的サンプルの正確な保存が必要です。このような個別化医療への注目は、多様な生物学的データの収集、保存、分析をサポートするバイオ保存ソリューションの開発機会を生み出しています。

バイオ保存市場の課題は以下の通りである：

• 先端技術のコスト高：高度なバイオ保存技術に伴う高コストが大きな障壁となる可能性があります。最先端の凍結保存システム、保存施設、モニタリング機器への投資には多額の資金が必要となります。中小企業や研究機関にとって、こうしたコストは最新技術へのアクセスを制限し、市場での競争力に影響を与える可能性があります。
• 規制の遵守：厳しい規制要件の遵守が、バイオ保存市場の課題となっています。生物材料の保存とマテリアルハンドリングに関する規制は複雑で、地域によって異なります。これらの規制を確実に遵守するためには、保存方法の継続的な更新と品質管理対策への投資が必要であり、複数の管轄区域で事業を展開する企業にとっては多大なリソースが必要となります。
• 技術の統合と標準化：新技術を既存のシステムに統合し、業界全体で標準化を達成することは、課題です。バイオ保存の実践に統一された基準がないため、サンプルの品質や保存結果にばらつきが生じる可能性があります。標準化されたプロトコールと技術を開発し採用することは、信頼性を確保し、市場全体に広く普及させるために不可欠です。

バイオ保存市場は様々な促進要因・課題によって形成されています。技術の進歩、バイオバンク需要の増加、再生医療の成長、医薬品市場の拡大、個別化医療への注目が市場成長を促進する主な要因です。しかし、高コスト、規制遵守、技術統合の課題が市場のダイナミクスに影響を与えています。促進要因を活用しながらこれらの課題に対処することは、利害関係者が進化するバイオ保存の状況を効果的にナビゲートする上で極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオ保存市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2019年から2031年までの市場動向と予測分析

• マクロ経済動向（2019-2024年）と予測（2025-2031年）
• 世界のバイオ保存市場の動向（2019～2024年）と予測（2025～2031年）
• タイプ別
  • メディア
  • 装置
• 生物検体別
  • 人間の組織
  • 幹細胞
  • 臓器
• 用途別
  • 治療薬
  • 調査
  • 臨床試験
• 最終用途産業別世界のバイオ保存市場
  • 病院
  • バイオバンク
  • 遺伝子バンク
  • その他

第4章 2019年から2031年までの地域別市場動向と予測分析

• 地域別：世界のバイオ保存市場
• 北米のバイオ保存市場
• 欧州のバイオ保存市場
• アジア太平洋のバイオ保存市場
• その他地域のバイオ保存市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • タイプ別
  • 生物検体別
  • 用途別
  • 最終用途産業別
  • 地域別
• 世界のバイオ保存市場の新たな動向
• 戦略分析
  • 新製品開発
  • 世界のバイオ保存市場の能力拡大
  • 世界のバイオ保存市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 主要企業の企業プロファイル

• Thermo Fisher Scientific
• Merck
• Avantor
• ThermoGenesis
• Bio-Techne Corporation
• BioLife Solutions
• Exact Sciences Corporation
• Worthington Industries
• Chart Industries

The future of the global biopreservation market looks promising with opportunities in the hospital, biobank, and gene bank markets. The global biopreservation market is expected to reach an estimated $17 billion by 2031 with a CAGR of 28.1% from 2025 to 2031. The major drivers for this market are increasing R&D investments, advancements in biobanking, the growing trend of conserving cord blood stem cells of newborns, rising investments in regenerative medicine research, and increasing demand for personalized medicine.

• Lucintel forecasts that, Within the type category, equipment is expected to witness higher growth over the forecast period due to increasing demand for bio-banks, extensive usage in DNA, plasma, stem cell, and tissue research, widespread adoption, high-cost efficiency, and low maintenance.
• Within the end use industry category, biobanks will remain the largest segment due to growing awareness of biopreservation among researchers, an increasing number of sperm and egg banks, the adoption of assisted reproductive technology, a collaboration of biopharmaceutical companies with national bio-banks, and tissue preservation centers at hospitals.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to consistent drug developments and advanced therapies in the field of biomedical research, rise in patient base requiring high-end treatment for chronic diseases, and high demand for biopreservation products and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biopreservation Market

The biopreservation market is witnessing several transformative trends that reshape the field. These trends reflect advancements in technology, evolving market demands, and the growing importance of maintaining the integrity of biological materials. Understanding these trends helps stakeholders anticipate future developments and adapt their strategies accordingly.

• Increased Use of Artificial Intelligence (AI): AI is revolutionizing biopreservation by enhancing the monitoring and management of storage conditions. AI-driven systems analyze real-time data to optimize preservation protocols, predict potential issues, and automate responses. This technology improves the reliability and efficiency of biopreservation processes, reducing human error and ensuring better outcomes for biological samples. AI's predictive capabilities also facilitate proactive maintenance of preservation equipment, minimizing risks and extending sample viability.
• Sustainable Biopreservation Solutions: There is a growing emphasis on sustainable biopreservation methods, driven by environmental concerns and regulatory pressures. Innovations include the development of eco-friendly cryoprotectants and energy-efficient storage systems. These solutions aim to reduce the environmental footprint of biopreservation processes while maintaining high standards of sample integrity. Sustainable practices are becoming essential for companies looking to enhance their corporate responsibility and comply with emerging environmental regulations.
• Advances in Cryopreservation Technologies: Cryopreservation continues to evolve, with new technologies improving sample storage and recovery. Recent advancements include enhanced cryoprotectants that reduce ice crystal formation and novel cooling techniques that improve cell viability. These innovations address previous limitations in cryopreservation, such as damage during thawing and long-term storage challenges, thereby supporting the growing demand for high-quality biological samples in research and clinical applications.
• Expansion of Biobanking Facilities: The expansion of biobanking is a significant trend, driven by the increasing demand for biological samples in research and personalized medicine. New biobank facilities are being established globally, focusing on increasing capacity and improving sample management. This expansion supports advancements in genomics, proteomics, and other fields, providing researchers with diverse and high-quality sample repositories for studying diseases, developing treatments, and advancing scientific knowledge.
• Integration of Regenerative Medicine and Biopreservation: The integration of regenerative medicine with biopreservation is transforming the field, particularly in stem cell research and cell therapies. Advances in biopreservation techniques are critical for maintaining the viability of cells and tissues used in regenerative medicine. Innovations in storage methods and cryopreservation protocols enhance the effectiveness of cell-based therapies and support the development of personalized treatments, making biopreservation a key component in the future of regenerative medicine.

These emerging trends significantly reshape the biopreservation market by driving innovation, enhancing sustainability, and expanding capabilities. AI and advanced technologies improve efficiency and reliability, while sustainable practices address environmental concerns. The growth of biobanking facilities and the integration of regenerative medicine further highlight the evolving landscape. Together, these trends set new standards for biopreservation, supporting advances in research, clinical applications, and personalized medicine.

Recent Developments in the Biopreservation Market

The biopreservation market reflects advancements in technology, regulatory frameworks, and market demands. These key developments transform how biological materials are preserved, with significant implications for research, pharmaceuticals, and healthcare. Understanding these developments provides insight into how the market evolves and the factors driving innovation in biopreservation.

• Development of Advanced Cryopreservation Systems: Recent advancements in cryopreservation systems have led to improved preservation of biological materials. New technologies, such as advanced cryoprotectants and more efficient cooling methods, enhance cell viability and reduce damage during thawing. These systems address previous limitations and support the growing demand for high-quality samples in research and clinical applications. The development of these systems is crucial for maintaining the integrity of biological samples and advancing scientific and medical research.
• Growth of Biobank Infrastructure: The expansion of biobank infrastructure is a notable development, with new facilities established worldwide. This growth supports the increasing need for biological samples in research and personalized medicine. Enhanced biobank infrastructure includes improved sample management systems, larger storage capacities, and better data integration. This development facilitates more extensive and diverse research, contributing to advancements in genomics, proteomics, and disease understanding.
• Innovations in Sample Storage Technologies: Innovations in sample storage technologies drive improvements in biopreservation. Advances include the development of energy-efficient storage systems and novel materials that enhance sample stability. These innovations address the challenges of long-term storage and reduce operational costs. Improved storage technologies ensure the integrity of biological samples, supporting their use in research and clinical applications.
• Enhanced Regulatory Frameworks: Enhanced regulatory frameworks shape the biopreservation market by setting higher standards for sample preservation and management. Recent changes in regulations focus on ensuring the quality and safety of biological materials. Compliance with these regulations requires the adoption of advanced preservation techniques and rigorous quality control measures. These regulatory developments support the growth of the biopreservation market by establishing clear guidelines and promoting best practices.
• Increased Focus on Personalized Medicine: The increasing focus on personalized medicine drives advancements in biopreservation. Personalized medicine relies on high-quality biological samples for developing tailored treatments and therapies. Recent developments include improved preservation methods that support the storage and analysis of samples for personalized medicine applications. This focus on personalized medicine expands the role of biopreservation in drug development and patient care.

The biopreservation market enhances preservation techniques, expands infrastructure, and improves regulatory standards. Advances in cryopreservation systems, biobank growth, and storage technologies are crucial for maintaining sample integrity. Enhanced regulations and the focus on personalized medicine further shape the market, driving innovation and supporting the evolution of biopreservation practices. These developments collectively contribute to the advancement of research, pharmaceuticals, and healthcare.

Strategic Growth Opportunities for Biopreservation Market

The biopreservation market is expanding rapidly, driven by technological advancements and growing applications across various sectors. Key growth opportunities are emerging in several applications, reflecting the increasing need for effective preservation methods to ensure the quality and integrity of biological materials. These opportunities span areas such as biobanking, regenerative medicine, pharmaceutical development, diagnostics, and personalized medicine. Understanding these opportunities helps stakeholders align their strategies to capitalize on market growth and innovation.

• Expansion in Biobanking: Biobanking is a significant growth area due to the increasing demand for large-scale, high-quality biological sample repositories. The development of advanced biobank infrastructure and improved sample management technologies enable better collection, storage, and utilization of samples. This expansion supports research in genomics, personalized medicine, and drug discovery by providing a diverse range of well-preserved biological materials. Investment in biobanking infrastructure can enhance research capabilities and facilitate breakthroughs in understanding diseases and developing targeted therapies.
• Advancements in Regenerative Medicine: Regenerative medicine creates substantial growth opportunities in biopreservation. Techniques such as stem cell therapy and tissue engineering require precise preservation methods to maintain cell viability and functionality. Innovations in cryopreservation and storage technologies are critical for supporting these applications. As regenerative medicine advances, the need for reliable biopreservation solutions grows, providing opportunities for companies to develop specialized technologies that cater to the unique requirements of regenerative therapies and enhance their efficacy.
• Growth in Pharmaceutical Development: The pharmaceutical industry's focus on biopharmaceuticals and complex drugs drives demand for advanced biopreservation methods. The preservation of biologics, such as monoclonal antibodies and vaccines, requires stringent control over storage conditions to ensure product stability and efficacy. Opportunities exist for developing new preservation technologies that improve the shelf life and handling of these sensitive products. As pharmaceutical companies seek to optimize their biopreservation processes, there is potential for significant growth in this sector.
• Innovations in Diagnostic Testing: The increasing complexity and volume of diagnostic testing create opportunities for biopreservation in managing and storing diagnostic samples. Advances in preservation technologies can improve sample quality, accuracy, and reliability in diagnostics. The development of robust biopreservation solutions that can handle diverse types of samples, including blood, tissue, and genetic material, is crucial for supporting the growing diagnostic industry. This creates a niche market for innovative preservation technologies that enhance diagnostic testing capabilities.
• Personalized Medicine: Personalized medicine is expanding rapidly, necessitating advanced biopreservation solutions for tailoring treatments based on individual genetic profiles. The preservation of genomic, proteomic, and other biological data is essential for developing and delivering personalized therapies. Companies have opportunities to create specialized biopreservation systems that support the growing volume of personalized medicine research and applications. By addressing the specific needs of personalized medicine, biopreservation providers can tap into a burgeoning market focused on individualized patient care.

The strategic growth opportunities in biopreservation span biobanking, regenerative medicine, pharmaceutical development, diagnostic testing, and personalized medicine. Each application presents unique opportunities for technological innovation and market expansion. By leveraging these opportunities, stakeholders can enhance their offerings, support advancements in related fields, and contribute to the overall growth of the biopreservation market.

Biopreservation Market Driver and Challenges

The biopreservation market is influenced by a range of drivers and challenges, including technological advancements, economic factors, and regulatory frameworks. Understanding these factors is crucial for navigating the market and identifying growth opportunities. The following analysis explores the key drivers and challenges shaping the biopreservation industry, highlighting their implications and impact.

The factors responsible for driving the biopreservation market include:

• Technological Advancements: Technological innovations in cryopreservation, storage systems, and monitoring technologies are major drivers of growth in the biopreservation market. Advances such as improved cryoprotectants, automated storage solutions, and real-time monitoring systems enhance the efficiency and reliability of preservation methods. These technologies address previous limitations, reduce costs, and support the development of new applications in research, pharmaceuticals, and personalized medicine.
• Increasing Demand for Biobanking: The growing demand for biobanking is a significant driver of the biopreservation market. Biobanks are essential for storing large volumes of biological samples for research and clinical applications. As personalized medicine, genomics, and drug discovery advance, the need for extensive and well-preserved sample repositories increases. Investment in biobank infrastructure and technologies is crucial for meeting this demand and supporting ongoing research and development efforts.
• Growth of Regenerative Medicine: The rise of regenerative medicine, including stem cell therapies and tissue engineering, is driving demand for advanced biopreservation methods. Effective preservation of cells, tissues, and organs is essential for maintaining their viability and functionality. Innovations in cryopreservation and storage techniques cater to the specific needs of regenerative medicine, creating growth opportunities for companies developing specialized preservation solutions.
• Expansion of Pharmaceutical and Biopharmaceutical Markets: The expansion of the pharmaceutical and biopharmaceutical markets, driven by the development of biologics and complex drugs, is fueling demand for biopreservation solutions. Biopharmaceuticals require stringent preservation conditions to ensure stability and efficacy. Advances in preservation technologies that enhance the shelf life and handling of these products are critical for supporting the growth of this sector.
• Increasing Focus on Personalized Medicine: Personalized medicine drives growth in the biopreservation market by requiring advanced preservation methods for genetic, proteomic, and other biological data. The ability to tailor treatments based on individual profiles necessitates precise preservation of biological samples. This focus on personalized medicine creates opportunities for developing biopreservation solutions that support the collection, storage, and analysis of diverse biological data.

Challenges in the biopreservation market are:

• High Costs of Advanced Technologies: The high costs associated with advanced biopreservation technologies can be a significant barrier. Investment in cutting-edge cryopreservation systems, storage facilities, and monitoring equipment requires substantial financial resources. For smaller companies and research institutions, these costs can limit access to the latest technologies and impact their ability to compete in the market.
• Regulatory Compliance: Compliance with stringent regulatory requirements poses a challenge for the biopreservation market. Regulations governing the storage and handling of biological materials are complex and vary by region. Ensuring adherence to these regulations requires continuous updates to preservation practices and investments in quality control measures, which can be resource-intensive for companies operating in multiple jurisdictions.
• Technological Integration and Standardization: Integrating new technologies with existing systems and achieving standardization across the industry can be challenging. The lack of uniform standards for biopreservation practices can lead to inconsistencies in sample quality and preservation outcomes. Developing and adopting standardized protocols and technologies is essential for ensuring reliability and facilitating widespread adoption across the market.

The biopreservation market is shaped by various drivers and challenges. Technological advancements, increasing demand for biobanking, growth in regenerative medicine, expansion of pharmaceutical markets, and the focus on personalized medicine are key drivers propelling market growth. However, high costs, regulatory compliance, and technological integration challenges impact the market's dynamics. Addressing these challenges while leveraging growth drivers will be crucial for stakeholders to navigate the evolving biopreservation landscape effectively.

List of Biopreservation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. through these strategies biopreservation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biopreservation companies profiled in this report include-

• Thermo Fisher Scientific
• Merck
• Avantor
• ThermoGenesis
• Bio-Techne Corporation
• BioLife Solutions
• Exact Sciences Corporation
• Worthington Industries
• Chart Industries

Biopreservation by Segment

The study includes a forecast for the global biopreservation by type, biospecimen, application, end use industry, and region.

Biopreservation Market by Type [Analysis by Value from 2019 to 2031]:

• Media
• Equipment

Biopreservation Market by Biospecimen [Analysis by Value from 2019 to 2031]:

• Human Tissue
• Stem Cells
• Organs

Biopreservation Market by Application [Analysis by Value from 2019 to 2031]:

• Therapeutics
• Research
• Clinical Trials

Biopreservation Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals
• Biobanks
• Gene Banks
• Others

Biopreservation Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biopreservation Market

The biopreservation market is experiencing rapid advancements driven by innovations in technology, regulatory changes, and increasing demand for quality and safety in biopharmaceuticals and healthcare. These developments reshape how biological samples and products are preserved, extending their shelf life and ensuring their integrity. This analysis explores recent developments in the United States, China, Germany, India, and Japan, highlighting key advancements and shifts in each region's biopreservation landscape.

• United States: In the U.S., the biopreservation market is driven by innovations in cryopreservation and the adoption of advanced biopreservation systems. Recent developments include the integration of artificial intelligence for monitoring and optimizing storage conditions. Additionally, the FDA's regulatory support for personalized medicine has spurred growth in biobanking, enhancing research capabilities. Companies are investing in more sophisticated refrigeration technologies and data management systems to ensure the integrity of biological samples, facilitating advances in drug development and personalized therapies.
• China: China is rapidly advancing in biopreservation due to increasing investments in biotechnology and healthcare infrastructure. Recent developments include significant improvements in cryopreservation techniques and the establishment of large-scale biobanks. The government has also implemented supportive policies to foster innovation and collaboration in biopreservation research. Chinese firms focus on developing cost-effective and efficient biopreservation solutions to support the growing demand for biological samples in research and clinical applications, positioning the country as a key player in the global market.
• Germany: Germany is leading in the European biopreservation market with a strong emphasis on technological innovation and sustainability. Recent advancements include the development of new materials and technologies for more efficient cryopreservation and storage. German companies are also exploring novel biopreservation methods that reduce environmental impact, such as eco-friendly cryoprotectants. The country's robust research infrastructure and collaboration between academia and industry drive advancements in preserving biological materials for pharmaceutical and research purposes.
• India: India is making strides in biopreservation, particularly in the context of biobanking and pharmaceutical research. Recent developments include the expansion of biobank facilities and improvements in cryopreservation technologies tailored to regional needs. Indian companies and research institutions increasingly adopt advanced preservation techniques to enhance the quality and reliability of biological samples. Government initiatives and private investments boost the biopreservation sector, supporting growth in personalized medicine and research capabilities.
• Japan: The Japanese biopreservation market is characterized by its focus on high-tech solutions and integration with cutting-edge research. Recent developments include advancements in cryopreservation technology and the adoption of sophisticated biopreservation systems. Japan is also at the forefront of developing new preservation techniques to support regenerative medicine and cell therapies. The country's strong emphasis on innovation and its supportive regulatory environment drive the evolution of biopreservation practices, enhancing the quality and efficiency of biological sample storage.

Features of the Global Biopreservation Market

Market Size Estimates: Biopreservation market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Biopreservation market size by various segments, such as by type, biospecimen, application, end use industry, and region in terms of value ($B).

Regional Analysis: Biopreservation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, biospecimen, application, end use industry, and regions for the biopreservation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biopreservation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biopreservation market by type (media and equipment), biospecimen (human tissue, stem cells, and organs), application (therapeutics, research, and clinical trials), end use industry (hospitals, biobanks, gene banks, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biopreservation Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Biopreservation Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Biopreservation Market by Type
  • 3.3.1: Media
  • 3.3.2: Equipment
• 3.4: Global Biopreservation Market by Biospecimen
  • 3.4.1: Human Tissue
  • 3.4.2: Stem Cells
  • 3.4.3: Organs
• 3.5: Global Biopreservation Market by Application
  • 3.5.1: Therapeutics
  • 3.5.2: Research
  • 3.5.3: Clinical Trials
• 3.6: Global Biopreservation Market by End Use Industry
  • 3.6.1: Hospitals
  • 3.6.2: Biobanks
  • 3.6.3: Gene Banks
  • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Biopreservation Market by Region
• 4.2: North American Biopreservation Market
  • 4.2.1: North American Biopreservation Market by Type: Media and Equipment
  • 4.2.2: North American Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
• 4.3: European Biopreservation Market
  • 4.3.1: European Biopreservation Market by Type: Media and Equipment
  • 4.3.2: European Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
• 4.4: APAC Biopreservation Market
  • 4.4.1: APAC Biopreservation Market by Type: Media and Equipment
  • 4.4.2: APAC Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others
• 4.5: ROW Biopreservation Market
  • 4.5.1: ROW Biopreservation Market by Type: Media and Equipment
  • 4.5.2: ROW Biopreservation Market by End Use Industry: Hospitals, Biobanks, Gene Banks, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biopreservation Market by Type
  • 6.1.2: Growth Opportunities for the Global Biopreservation Market by Biospecimen
  • 6.1.3: Growth Opportunities for the Global Biopreservation Market by Application
  • 6.1.4: Growth Opportunities for the Global Biopreservation Market by End Use Industry
  • 6.1.5: Growth Opportunities for the Global Biopreservation Market by Region
• 6.2: Emerging Trends in the Global Biopreservation Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biopreservation Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biopreservation Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Merck
• 7.3: Avantor
• 7.4: ThermoGenesis
• 7.5: Bio-Techne Corporation
• 7.6: BioLife Solutions
• 7.7: Exact Sciences Corporation
• 7.8: Worthington Industries
• 7.9: Chart Industries